本页面由Tiger Trade Technology Pte. Ltd.提供服务

奥洛兹美医疗

111.08
+0.66000.60%
成交量:166.03万
成交额:1.85亿
市值:126.07亿
市盈率:32.84
高:112.43
开:110.19
低:109.96
收:110.42
52周最高:116.85
52周最低:61.23
股本:1.13亿
流通股本:1.12亿
量比:0.82
换手率:1.48%
股息:- -
股息率:- -
每股收益(TTM):3.38
每股收益(LYR):2.56
净资产收益率:173.67%
总资产收益率:25.49%
市净率:87.83
市盈率(LYR):43.39

数据加载中...

2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

SEC问询函

Form CORRESP - Correspondence
2023/06/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]